drugset / Trial / NCT00600990
Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to determine the effectiveness of this medication in preventing nausea and vomiting in female patients at risk for post-operative nausea and vomiting (PONV).
Timeline
- Start
- 2004-12
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vestipitant | Small molecule | 3 mg | Oral |
| Subject | Vestipitant | Small molecule | 18 mg | Oral |
| Subject | Vestipitant | Small molecule | 25 mg | Oral |
Indications
No indication recorded.